Century Therapeutics, Inc. IPSC
1.67
(0.02)
(1.18%)
as of 25 Sep
- Market cap
- $306.0M
- P/E
- 0.0×
Follow IPSC
Insider Buys
alert about insiders buying in the last 12 month
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | 55.21 | 96.60 | 12.06 | 0.75 |
P/FCF ratio |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | — | (12.53) | (8.23) | (3.28) | (5.38) |
P/B ratio |
— | — | — | — | 0.95 | 1.17 | 0.49 | 0.54 |
Price to Tangible BV |
— | — | — | — | 0.95 | 1.17 | 0.62 | 0.69 |
EV/Sales |
— | — | — | — | (3.20) | 19.60 | (16.66) | (0.27) |
EV/EBITDA |
— | — | — | — | 0.13 | 0.00 | 0.85 | 4.68 |
EV/Operating CF |
— | — | — | — | (1.18) | (0.50) | 1.00 | 0.29 |
EV/FCF |
— | — | — | — | 1.00 | (0.43) | 1.00 | 0.29 |
Quick Ratio |
— | 27.28 | 6.25 | 14.24 | 10.58 | 9.68 | 1.46 | 5.79 |
Current Ratio |
— | 28.10 | 6.51 | 14.57 | 10.72 | 9.92 | 1.50 | 5.97 |
Net Debt/EBITDA |
— | 4.12 | 1.26 | 2.31 | 2.43 | 1.25 | 1.46 | 17.95 |
Debt/Assets |
0.00% | 0.00% | 9.25% | 2.96% | 2.43% | 0.18% | 0.02% | 0.01% |
Debt/Equity |
— | 0.00 | 0.13 | 0.03 | 0.04 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.38 |
Operating CF/Net income |
— | 0.07 | 0.77 | 0.93 | (0.11) | 0.65 | 0.87 | 10.84 |
Capex/Depreciation |
— | 0.00 | (6.58) | (11.09) | (3.50) | (1.50) | (0.02) | (0.08) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | (186.03%) | 83.53% | (66.13%) | (37.46%) | (56.07%) | (73.14%) | (5.98%) | |
| — | (304.26%) | (40.03%) | (35.22%) | (28.34%) | (32.26%) | (35.46%) | (3.32%) | |
ROIC |
— | 0.00% | (450.83%) | (31.83%) | 0.00% | (723.93%) | 0.00% | (25.79%) |
Return on Tangible Assets |
— | (292.73%) | (65.28%) | (35.43%) | (35.13%) | (59.20%) | (100.12%) | (6.36%) |
Average Days of Receivables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 2,061.42% | 4,371.81% | 1,627.62% | 87.64% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 612.75% | 1,552.84% | 503.19% | 21.99% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.15 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | 205.21% | 654.23% | 192.56% | 6.27% |
Graham Net Nets |
— | — | — | — | 0.47 | 0.00 | 0.03 | 0.65 |
Graham Number |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | (45.88%) | (62.91%) | (161.39%) | (14.00%) |
Free Cash Flow Yield |
— | — | — | — | (5.77%) | (47.28%) | (138.84%) | (120.99%) |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.09 | 0.04 | 0.08 | 1.26 |
Operating CF per Share |
— | (0.29) | (5.52) | (2.75) | 0.24 | (1.49) | (1.40) | (1.20) |
Capex per Share |
— | 0.00 | (1.31) | (1.39) | (0.53) | (0.23) | 0.00 | (0.01) |
Free Cash Flow per Share |
— | (0.29) | (6.83) | (4.14) | (0.29) | (1.72) | (1.40) | (1.21) |
Cash per Share |
— | 1.49 | 10.12 | 6.88 | 5.46 | 2.91 | 2.41 | 1.35 |
Shareholders Equity per Share |
— | 2.88 | 9.80 | 12.23 | 5.24 | 3.11 | 2.05 | 1.84 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 2.88 | 9.80 | 12.23 | 5.24 | 3.11 | 2.05 | 1.84 |
Free Cash Flow |
— | (16.17) | (51.09) | (133.97) | (16.55) | (102.08) | (110.29) | (104.72) |
Working Capital |
— | 81.13 | 66.69 | 212.50 | 289.90 | 159.15 | 64.27 | 100.54 |
Capital Expenditures |
— | (2.46) | (9.82) | (44.97) | (30.60) | (13.74) | (0.15) | (0.85) |
Net Current Asset Value |
— | 81.13 | 45.37 | 187.02 | 135.92 | 1.05 | 2.20 | 56.00 |
EV/EBIT |
— | — | — | — | 0.12 | 0.00 | 0.79 | 1.77 |
Capex to Sales |
— | — | 0.00 | 0.00 | 5.89 | 6.15 | 0.02 | 0.01 |
Net Profit Margin |
— | 0.00% | 0.00% | 0.00% | (2,518.41%) | (6,115.12%) | (1,920.87%) | (8.78%) |
Price to Operating Income |
— | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 0.10 | 0.10 | 0.07 | 0.11 | 0.13 | 0.14 | 0.21 |
Cash ROIC |
— | (7.79%) | (35.64%) | (23.25%) | (10.91%) | (44.69%) | (49.12%) | (55.75%) |
Accounts Receivable Turnover |
— | 0.00 | 0.00 | 0.00 | 10.10 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
— | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | 2,269.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Receivables |
— | 0.52 | 0.52 | 0.58 | 0.52 | — | — | — |
Average Payables |
— | 4.82 | 4.82 | 7.84 | 6.53 | 4.10 | 2.91 | 3.92 |
Average Assets |
— | 80.45 | 133.84 | 272.08 | 461.96 | 423.62 | 356.95 | 288.46 |
Average Common Equity |
— | 131.58 | (64.14) | 144.91 | 349.49 | 243.74 | 173.06 | 160.15 |
Columns are period end dates